The current valuation score of argenx SE is 9.98, ranking 1 out of 377 in the Biotechnology & Medical Research industry. Its current P/E ratio is 41.62, which is 15.97% below the recent high of 48.27 and 2267.81% above the recent low of -902.21.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.